Current News SFA Therapeutics announced positive results from their SFA-002 Phase 1b cohort 1 clinical trial for the treatment of mild-to-moderate chronic plaque psoriasis Posted on August 21, 2023August 22, 2023 by Cort Meyerson 21 Aug Cort Meyerson C2i Genomics announced its strategic collaboration with the Tel Aviv Sourasky Medical Center (Ichilov) to provide precision oncology clinical testing in Israel using C2inform, C2i Genomics’ whole genome minimal residual disease (MRD) test Inherent Biosciences has secured a $1.9M fast-track SBIR Grant from the National Institutes of Health (NIH)
